Ontology highlight
ABSTRACT: Background
Increasing use of genetic testing raises questions about disclosing secondary findings, including pleiotropic information.Objective
To determine the safety and behavioral effect of disclosing modest associations between apolipoprotein E (APOE) genotype and coronary artery disease (CAD) risk during APOE-based genetic risk assessments for Alzheimer disease (AD).Design
Randomized, multicenter equivalence clinical trial. (ClinicalTrials.gov: NCT00462917).Setting
4 teaching hospitals.Participants
257 asymptomatic adults were enrolled, 69% of whom had 1 AD-affected first-degree relative.Intervention
Disclosure of genetic risk information about AD and CAD (AD+CAD) or AD only (AD-only).Measurements
Primary outcomes were Beck Anxiet
SUBMITTER: Christensen KD
PROVIDER: S-EPMC4979546 | biostudies-literature | 2016 Feb
REPOSITORIES: biostudies-literature